Anne‐Renee Hartman

6.8k total citations · 2 hit papers
64 papers, 2.5k citations indexed

About

Anne‐Renee Hartman is a scholar working on Cancer Research, Genetics and Molecular Biology. According to data from OpenAlex, Anne‐Renee Hartman has authored 64 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cancer Research, 30 papers in Genetics and 28 papers in Molecular Biology. Recurrent topics in Anne‐Renee Hartman's work include Cancer Genomics and Diagnostics (30 papers), BRCA gene mutations in cancer (29 papers) and DNA Repair Mechanisms (13 papers). Anne‐Renee Hartman is often cited by papers focused on Cancer Genomics and Diagnostics (30 papers), BRCA gene mutations in cancer (29 papers) and DNA Repair Mechanisms (13 papers). Anne‐Renee Hartman collaborates with scholars based in United States, United Kingdom and Germany. Anne‐Renee Hartman's co-authors include James M. Ford, Brian Allen, Richard Wenstrup, Judy E. Garber, John Kidd, Nanda Singh, Nadine Tung, Rajesh Kaldate, Benjamin B. Roa and Eric P. Winer and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Anne‐Renee Hartman

61 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

2016 364 citations John Kidd, Brian Allen et al. Journal of Clinical Oncology profile →
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer

2017 344 citations Matthew B. Yurgelun, Brian Allen et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Anne‐Renee Hartman

Since Specialization

Citations

This map shows the geographic impact of Anne‐Renee Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Renee Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Renee Hartman more than expected).

Fields of papers citing papers by Anne‐Renee Hartman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Renee Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Renee Hartman. The network helps show where Anne‐Renee Hartman may publish in the future.

Co-authorship network of co-authors of Anne‐Renee Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Renee Hartman. A scholar is included among the top collaborators of Anne‐Renee Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Renee Hartman. Anne‐Renee Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 5024: Analytical performance of a genome-wide methylome enrichment platform to detect minimal residual disease from plasma-derived cell-free DNA 2024 ·Cancer Research ·Shu Yi Shen, Iulia Cirlan, (unknown), (unknown), (unknown), Justin Burgener, Junjun Zhang, Yulia Newton, Margaret Gruca, Abel Licon, Jing Zhang, Anne‐Renee Hartman, Abigail Williams, Hestia Mellert, Daniel D. De Carvalho	0
2	Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Eric A. Klein, Sarina Madhavan, Tomasz M. Beer, Chetan Bettegowda, Minetta C. Liu, Anne‐Renee Hartman, Allan Hackshaw	15
3	P1.11-19 Trial in Progress: Cancer Screening Study With or Without Low Dose Lung CT to Validate a Multi-Cancer Early Detection Blood Test 2019 ·Journal of Thoracic Oncology ·Sam M. Janes, Jennifer Dickson, Anand Devaraj, Carolyn Horst, Samantha L. Quaife, (unknown), (unknown), (unknown), Laura Farrelly, Brian Allen, (unknown), Christina A. Clarke, Stephanie Hamilton, Anne‐Renee Hartman, Allan Hackshaw	5
4	Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance 2017 ·Clinical Cancer Research ·Anosheh Afghahi, Kirsten M. Timms, Shaveta Vinayak, Kristin C. Jensen, Allison W. Kurian, Robert W. Carlson, (unknown), Elizabeth Schackmann, Anne‐Renee Hartman, James M. Ford, Melinda L. Telli	55
5	Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Jennifer S. Ko, Balwir Matharoo‐Ball, Steven D. Billings, Brian J. Thomson, Jean Y. Tang, Kavita Y. Sarin, (unknown), Jinah Kim, (unknown), (unknown), Darl D. Flake, M. Bryan Warf, Jonathan W. Nelson, Thaylon Davis, (unknown), Kristen Rushton, Anne‐Renee Hartman, Richard Wenstrup, Loren E. Clarke	50
6	Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women 2017 ·JCO Precision Oncology ·Allison W. Kurian, Elisha Hughes, Elizabeth A. Handorf, Alexander Gutin, Brian Allen, Anne‐Renee Hartman, Michael J. Hall	131
7	Genetic heterogeneity and survival among pancreatic adenocarcinoma (PDAC) patients with positive family history. 2016 ·Journal of Clinical Oncology ·Gloria M. Petersen, Kari G. Chaffee, Robert R. McWilliams, Neil Majithia, Brian Allen, John Kidd, Nanda Singh, Anne‐Renee Hartman, Ann L. Oberg	9
8	Association of ovarian cancer (OC) risk with mutations detected by multiple-gene germline sequencing in 95,561 women. 2016 ·Journal of Clinical Oncology ·Allison W. Kurian, Elisha Hughes, Elizabeth A. Handorf, Alexander Gutin, Brian Allen, Anne‐Renee Hartman, Michael J. Hall	2
9	Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma 2015 ·Journal of Cutaneous Pathology ·Loren E. Clarke, M. Bryan Warf, Darl D. Flake, Anne‐Renee Hartman, Steven R. Tahan, Christopher R. Shea, Pedram Gerami, Jane L. Messina, Scott R. Florell, Richard Wenstrup, Kristen Rushton, Kirstin M. Roundy, (unknown), Benjamin B. Roa, Kathryn A. Kolquist, Alexander Gutin, Steven D. Billings, Sancy A. Leachman	108
10	Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome 2015 ·Gastroenterology ·Matthew B. Yurgelun, Brian Allen, Rajesh Kaldate, Karla R. Bowles, Thaddeus Judkins, Praveen Kaushik, Benjamin B. Roa, Richard Wenstrup, Anne‐Renee Hartman, Sapna Syngal	184
11	Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells 2011 ·BMC Pharmacology ·Elizabeth Alli, (unknown), Anne‐Renee Hartman, Patrick S. Lin, Lisa McPherson, James M. Ford	36
12	Ductal Pattern Enhancement on Magnetic Resonance Imaging of the Breast Due to Ductal Lavage 2007 ·The Breast Journal ·Pejman Ghanouni, Allison W. Kurian, Daniel Margolis, Anne‐Renee Hartman, Meredith Mills, Sylvia K. Plevritis, James M. Ford, Bruce L. Daniel	3
13	The Problems with Risk Selection; Scientific and Psychosocial Aspects 2005 ·Recent results in cancer research ·Anne‐Renee Hartman	3
14	Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma 2004 ·Cancer ·Anne‐Renee Hartman, Bruce L. Daniel, Allison W. Kurian, Meredith Mills, Kent W. Nowels, Frederick M. Dirbas, Kerry Kingham, Nicki Chun, Robert J. Herfkens, James M. Ford, Sylvia K. Plevritis	62
15	Current comprehensive assessment and management of women at increased risk for breast cancer 2004 ·The American Journal of Surgery ·Alan B. Hollingsworth, S. Eva Singletary, Monica Morrow, Darius Francescatti, Joyce O’Shaughnessy, Anne‐Renee Hartman, (unknown), Freya Schnabel, Victor G. Vogel	29
16	BRCA1 and p53: compensatory roles in DNA repair 2003 ·Journal of Molecular Medicine ·Anne‐Renee Hartman, James M. Ford	40
17	Phase I Trial of Uracil–Ftorafur, Leucovorin, and Etoposide: An Active All-oral Regimen for Metastatic Breast Cancer 2003 ·Breast Cancer Research and Treatment ·Anne‐Renee Hartman, (unknown), Bert L. Lum, Robert W. Carlson, (unknown), Branimir I. Šikić, (unknown), Frank E. Stockdale	3
18	BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair 2002 ·Nature Genetics ·Anne‐Renee Hartman, James M. Ford	192
19	Meta-Analysis of Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy in Postmenopausal Women with Estrogen Receptor–Positive, Node-Positive Breast Cancer 2001 ·Clinical Breast Cancer ·Anne‐Renee Hartman, Gini F. Fleming, John Dillon	14
20	New Bilateral Microcalcifications at Mammography in a Postlactational Woman: Case Report 2000 ·Radiology ·(unknown), Debra M. Ikeda, Anne‐Renee Hartman, Tracy I. George, Kent W. Nowels, (unknown), Don R. Goffinet, Robert W. Carlson	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact